A comprehensive assessment of RNA-seq protocols for degraded and low-quantity samples

Sven Schuierer1, Walter Carbone2, Judith Knehr2

  • 1Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland. sven.schuierer@novartis.com.

BMC Genomics
|June 7, 2017
PubMed
Abstract